In-silico expectations of pharmaceutical industry to design of new drug molecules
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i03.pp95-103Abstract
Increasing costs of drug development and reduced number of new chemical entities have been a growing concern for new drug development in recent years. A number of potential reasons for this outcome have been considered. One of them is a general perception that applied sciences have not kept pace with the advances of basic sciences. Therefore, there is a need for the use of alternative tools to get answers on efficacy and safety, with more certainty and at lower cost. One such alternative tool is the in silico drug design or the computer aided drug design (CADD). In Silico drug designing is a form of computer-based modeling whose technologies are applied in drug discovery processes. This approach has given tremendous opportunity of pharmaceutical industry to identify many new potential drugs than the conventional approaches. It emphasizes on how we can develop better and competitive drugs with the use of software and wet lab synchronization and the hope of developing better tools to facilitate human life the comfort and disease competitive
Keywords:
Drug Designing, In Silico, Molecular Modeling, Drug DiscoveryDownloads
References
Kuhlman J.: Drug research: from the idea to the product. Int. J. Clinical Pharm. and Therp. 1997; 35:541.
Fuller JC, Burgoyne NJ, Jackson RM.: Predicting druggable binding sites at the protein-protein interface. Drug Discovery Today 2009; 14:155-161.
Debouck C, Metcalf B: The impact of genomics on drug discovery. Annual Rev Pharmacology and toxicology 2004; 40:193‐208.
Burbaum J, Tobal G M: Proteomics in drug discovery. Current opinion chem. Bio. 2002; 6:427‐433.
Gatto, JG: The changing face of bioinformatics. Drug discovery today 2003; 8: 375‐376.
Greer J, Erickson WJ, Baldwin JJ, Varney MD.: Application of the three dimensional structures of protein target molecules in structure-based drug design. J. Med. Chem. 1994; 37:1035-1054.
Lengauer, T. and Rarey, M.: Computational methods for biomolecular docking. Current Opinion in Structural Biology 1996; 6:402-406.
Halperin, I., Wolfson, H. and Nussinov, R.: Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 2002; 47:409-443.
Wang, R., Lu, Y. Fang, X. and Wang, S.: An Extensive Test of 14 Scoring Functions Using the PDB bind Refined Set of 800 Protein-ligand Complexes. Journal of Chemical Information and Modeling 2004; 44:2114-2125.
Kontoyianni, M., McClellan, L.M. and Sokol, G.S.: Evaluation of docking performance: comparative data on docking algorithms. Journal of Medicinal Chemistry 2004; 47:558-65.
Mizuno, C. S., Chittiboyina, A. G. Shah, F. H. Patny, A. Kurtz, T. W. Speth, R. C. and Karamyan, V. T.: “Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome. Journal of Medicinal Chemistry 2010; 53:1076-1085.
Nazreen, S., Alam ,M.S Hamid, H. Yar, M.S. Shafi, S. Dhulap, A. Alam, P. and Pasha, M.A.: Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2, 4-diones bis-heterocycles as PPAR- γ agonists. European Journal of Medicinal Chemistry 2014; 16:175-185.
Teague, S.J.: Implications of protein flexibility for drug discovery. Nature Reviews Drug Discovery 2003; 2:527 – 541.
Murray, C.W., Baxter, C.A. and Frenkel, A.D: The sensitivity of the results of molecular docking to induced fit effects: application to thrombin, and neuraminidase. Journal of Computer-Aided Molecular Design 1999; 13:547 – 562.
Hansch, C., Maloney, P.P. and Fujita, T.: Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients. Nature 1962; 194:178 – 180.
Gupta, S.P., “QSAR Studies on Enzyme Inhibitors”, Chemical Reviews; 1987,87: 1183-1253.
Free, S.M. and Wilson, J.W.A.: Mathematical contribution to structure – activity studies. Journal of Medicinal Chemistry 1964; 7:395 – 399.
Fujita, T., Iwasa, J. and Hansch C: A new substituent constant, π, deri ved from partition coefficients. Journal of American Chemical Society 1964; 86:5175 – 5180.
Yasri, A. and Hartsough, D. J.: Toward an optimal procedure for variable selection and QSAR model building. J Chem Inf Comput Sci. 2001; 41:1218-1227.
Roy, P.P., Paul, S. Indrani, M. and Roy, K.: On two novel parameters for validation of predictive QSAR models. Molecules 2009; 14:1660-1701.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Ram Babu Tripathi, Milind Pande, Gaurav Garg, Deepanshu Sharma
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at